EIN: 860334996
UEI: PXS8JBQFYCZ9
Audited by: WIPFLI LLP
Oversight agency: 10 [Department of Agriculture]
View federal awards & risk assessment →
Data as of August 28, 2026
Management decision deadline — for entities that funded this organization
The FAC accepted this audit on January 6, 2026. Under 2 CFR 200.521(d), a pass-through entity that provided federal funds to this organization for this audit period must issue a management decision on these findings by July 6, 2026 (54 days ago).
What is a management decision? →FAC accepted this audit on January 16, 2025 — management decision was due July 16, 2025.
FAC accepted this audit on March 28, 2024 — management decision was due September 28, 2024.
FAC accepted this audit on November 21, 2022 — management decision was due May 21, 2023.
FAC accepted this audit on September 13, 2022 — management decision was due March 13, 2023.
The Organization?s internal controls over compliance related to reporting of allowable costs was not effective. Criteria: The Provider Relief Funds were provided under the Coronavirus Aid, Relief, and Economic Security Act (Pub. L. No. 116-136, 134 Stat. 563) and are to be used to prevent, prepare for, and respond to coronavirus and that the funds shall reimburse the recipient only for health care related expenses or lost revenues that are attributable to coronavirus. Guidance provided for the Provider Relief Fund further states that Provider Relief Fund payments cannot be used to cover costs that are reimbursed from other sources or other sources are obligated to reimburse. Context: The Organization receives cost-based reimbursement from Medicare through the annually filed cost report. As a result, allowable costs reported needed to factor in and exclude any amounts that are reimbursed though the annual cost report. Cause: Changing guidance and interpretations as to what were considered allowable costs per the terms and conditions of the Provider Relief Fund program required constant monitoring of the guidance being posted to the Provider Relief Fund website. HRSA guidance provided via responses to frequently asked questions was modified as late as October 26, 2021. Effect: Based on the 2021 Medicare cost report reimbursing about 18.3% of the Organization?s total costs, auditor estimated that approximately $186,511 in reported expenses could potentially be reimbursed through the cost report. Since the Organization reported lost revenues of approximately $2,040,000 more than Provider Relief Fund reimbursement for lost revenues, there was sufficient remaining lost revenue to offset the overreporting of expenses that could be partially reimbursed through the cost report. Therefore, no funds were estimated to be due back to the Provider Relief Fund. Questioned Costs: None. Recommendation: We recommend the Organization include in its controls over expenditures of federal awards the process of having an individual familiar with the award periodically review or monitor guidance that may be published by federal grantors. In addition, management should work with HRSA to reopen its reporting portal as this could impact the ability to claim future expenses and/or lost revenue related to future Provider Relief Funds amounts received. View of Responsible Officials: Management agrees with the finding and has prepared a corrective action plan.
Show full finding ▾Hide full finding ▴Finding 2021-001 Program Name/CFDA Title: Provider Relief Fund Federal Assistance Listing Number: 93.498 Federal Agency: U.S. Department of Health and Human Services Type of Finding: Internal Control, Significant Deficiency Compliance Requirement: Allowable Costs Condition: The Organization?s internal controls over compliance related to reporting of allowable costs was not effective. Criteria: The Provider Relief Funds were provided under the Coronavirus Aid, Relief, and Economic Security Act (Pub. L. No. 116-136, 134 Stat. 563) and are to be used to prevent, prepare for, and respond to coronavirus and that the funds shall reimburse the recipient only for health care related expenses or lost revenues that are attributable to coronavirus. Guidance provided for the Provider Relief Fund further states that Provider Relief Fund payments cannot be used to cover costs that are reimbursed from other sources or other sources are obligated to reimburse. Context: The Organization receives cost-based reimbursement from Medicare through the annually filed cost report. As a result, allowable costs reported needed to factor in and exclude any amounts that are reimbursed though the annual cost report. Cause: Changing guidance and interpretations as to what were considered allowable costs per the terms and conditions of the Provider Relief Fund program required constant monitoring of the guidance being posted to the Provider Relief Fund website. HRSA guidance provided via responses to frequently asked questions was modified as late as October 26, 2021. Effect: Based on the 2021 Medicare cost report reimbursing about 18.3% of the Organization?s total costs, auditor estimated that approximately $186,511 in reported expenses could potentially be reimbursed through the cost report. Since the Organization reported lost revenues of approximately $2,040,000 more than Provider Relief Fund reimbursement for lost revenues, there was sufficient remaining lost revenue to offset the overreporting of expenses that could be partially reimbursed through the cost report. Therefore, no funds were estimated to be due back to the Provider Relief Fund. Questioned Costs: None. Recommendation: We recommend the Organization include in its controls over expenditures of federal awards the process of having an individual familiar with the award periodically review or monitor guidance that may be published by federal grantors. In addition, management should work with HRSA to reopen its reporting portal as this could impact the ability to claim future expenses and/or lost revenue related to future Provider Relief Funds amounts received. View of Responsible Officials: Management agrees with the finding and has prepared a corrective action plan.
Management of the organization will work with HRSA to update its documentation as well as update its internal records to reflect the current terms and conditions of the Provider Relief Funds related to allowable costs and reimbursement from other sources.
The Organization did not meet its requirements to use the funds received to prevent, prepare for, and respond to coronavirus and that the payment shall reimburse the recipient only for health care related expenses or lost revenue that are attributable to coronavirus. Criteria: The Provider Relief Funds were provided under the Coronavirus Aid, Relief, and Economic Security Act (Pub. L. No. 116-136, 134 Stat. 563) and are to be used to prevent, prepare for, and respond to coronavirus and that the funds shall reimburse the recipient only for health care related expenses or lost revenues that are attributable to coronavirus. Context: Included in the submission of allowable expenses to HRSA were ongoing expenses of the Organization such as mortgage payments on existing debt, utility payments, and insurance premiums that were not directly attributable to the COVID pandemic or caused to be incurred for the COVID pandemic. As such these expenses are not an allowable COVID expense under the Department of Health and Human Services guidelines for the use of Provider Relief Funds. However, it was noted that the Organization had sufficient unreimbursed lost revenue and additional COVID-related expenses, that were incurred but not included on Reporting Period 1 portal submission, to cover the disbursements noted above. The unreimbursed lost revenue and additional COVID-related expense would be sufficient to support retaining the grant funding. Cause: Management oversight. Effect: The Organization is not in compliance with federal regulations and guidelines surrounding the use of the Provider Relief Funds. Questioned Costs: None. Recommendation: We recommend that management review off COVID-related disbursements for allowability under the criteria provided by the Department of Health and Human Services. In addition, management should work with HRSA to reopen its reporting portal as this could impact the ability to claim expenses and/or lost revenue related to future Provider Relief Funds amounts received. View of Responsible Officials: Management agrees with the finding and has prepared a corrective action plan.
Show full finding ▾Hide full finding ▴Finding 2021-002 Program Name/CFDA Title: Provider Relief Fund Federal Assistance Listing Number: 93.498 Federal Agency: U.S. Department of Health and Human Services Type of Finding: Internal Control, Significant Deficiency Compliance Requirement: Allowable Cost Condition: The Organization did not meet its requirements to use the funds received to prevent, prepare for, and respond to coronavirus and that the payment shall reimburse the recipient only for health care related expenses or lost revenue that are attributable to coronavirus. Criteria: The Provider Relief Funds were provided under the Coronavirus Aid, Relief, and Economic Security Act (Pub. L. No. 116-136, 134 Stat. 563) and are to be used to prevent, prepare for, and respond to coronavirus and that the funds shall reimburse the recipient only for health care related expenses or lost revenues that are attributable to coronavirus. Context: Included in the submission of allowable expenses to HRSA were ongoing expenses of the Organization such as mortgage payments on existing debt, utility payments, and insurance premiums that were not directly attributable to the COVID pandemic or caused to be incurred for the COVID pandemic. As such these expenses are not an allowable COVID expense under the Department of Health and Human Services guidelines for the use of Provider Relief Funds. However, it was noted that the Organization had sufficient unreimbursed lost revenue and additional COVID-related expenses, that were incurred but not included on Reporting Period 1 portal submission, to cover the disbursements noted above. The unreimbursed lost revenue and additional COVID-related expense would be sufficient to support retaining the grant funding. Cause: Management oversight. Effect: The Organization is not in compliance with federal regulations and guidelines surrounding the use of the Provider Relief Funds. Questioned Costs: None. Recommendation: We recommend that management review off COVID-related disbursements for allowability under the criteria provided by the Department of Health and Human Services. In addition, management should work with HRSA to reopen its reporting portal as this could impact the ability to claim expenses and/or lost revenue related to future Provider Relief Funds amounts received. View of Responsible Officials: Management agrees with the finding and has prepared a corrective action plan.
Management of the organization will work with HRSA to update its documentation as well as update its internal records to reflect allowable costs under the program. Management will also develop a more detailed expense log and review those against current terms and conditions prior to any future portal submissions.
Data source: This information comes from the Federal Audit Clearinghouse, the official repository of Single Audit data. All data is public domain. Verify this organization's audit history at fac.gov.
Track your findings and corrective action plans across audit cycles.
Start tracking findings →Monitor subrecipient audit findings and filing records.
Start monitoring →© 2026 Single Audit Intelligence. All data is public domain.